Related Experiment Videos
[IgM myeloma: a report of 2 cases]
1Servicio de Medicina Interna, General Hospital Clínic i Provincial, Barcelona.
Medicina Clinica
|May 25, 1991
Summary
IgM myeloma, a rare plasma cell disorder, presents with bone lesions and deterioration, often without detectable M protein. Differentiating it from Waldenström macroglobulinemia is crucial for appropriate treatment and prognosis.
Area of Science:
- Hematology
- Oncology
Background:
- IgM myeloma is a rare subtype of multiple myeloma (MM).
- It exhibits distinct features compared to other MM immunologic types and Waldenström macroglobulinemia (WM).
Observation:
- Two cases of IgM myeloma are presented, characterized solely by bone lesions and general deterioration.
- Neither patient showed an M component in their proteinogram.
- Bone marrow plasma cell proliferation was observed in both, with one case showing dura mater infiltration.
Findings:
- Immunoglobulin analysis revealed IgM lambda in one patient and IgM kappa in the other.
- Both patients experienced a poor clinical course, succumbing to infective complications.
Implications:
- Accurate differentiation of IgM myeloma from WM is essential due to differing prognoses and therapeutic strategies.
- Highlights the importance of considering IgM myeloma in cases of unexplained bone lesions and deterioration, even without M component detection.